Date of Award
Master of Science in Nursing (MSN)
Amiodarone is a commonly used antiarrhythmic medication. When administered through a peripheral intravenous catheter, Amiodarone is associated with a high risk of phlebitis. Phlebitis is characterized by inflammation, swelling, redness, and pain at the vascular point of access and along the vascular route of administration. Phlebitis can cause a delay of treatment, infection, and prolonged hospital stays. A central line is the preferred IV administration route for Amiodarone due to its potential effects of vein irritation. Often times Amiodarone is administered in an emergent setting where attaining a central line is not feasible. Therefore, peripheral IV administration is routinely used placing the patient at a high risk of developing phlebitis.
A review of phlebitis; providing definitions, risk factors, and use of phlebitis scales was conducted. Next, the correlation between Amiodarone and phlebitis was examined; noting intrinsic factors, dose concentration, infusion duration, and nursing interventions. Conclusions were drawn addressing the severity of the correlation of Amiodarone and phlebitis. Amiodarone induced phlebitis incidence and educational needs at a local hospital were assessed. Through collaboration of experts, a patient educational tool and an implementation process were developed to aid in decreasing the Amiodarone induced phlebitis severity at the local hospital. The educational tool included definitions and signs and symptoms of phlebitis. The role of the IV team at the hospital and the role of the patient in [V surveillance were also included in the educational tool. Through education, patients can gain an understanding of phlebitis and the importance of participation in their healthcare. Patient involvement in IV surveillance is expected to result in earlier phlebitis detection; leading to a decrease in phlebitis severity
Snyder, Jill, "Amiodarone Induced Phlebitis" (2014). Theses and Dissertations. 4795.